HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Myriam Grattarola Selected Research

Ro 41-5253

11/2004Histone deacetylase inhibitors enhance retinoid response in human breast cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Myriam Grattarola Research Topics

Disease

2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2006 - 11/2003
1Edema (Dropsy)
06/2006
1Leprosy (Hansen's Disease)
06/2006
1Inflammation (Inflammations)
06/2006
1Carcinogenesis
11/2004
1Breast Neoplasms (Breast Cancer)
11/2004
1Neoplasms (Cancer)
11/2004

Drug/Important Bio-Agent (IBA)

2ChromatinIBA
11/2006 - 11/2003
1EnzymesIBA
06/2006
1EicosanoidsIBA
06/2006
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
06/2006
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
06/2006
1Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
06/2006
1Histone Deacetylase InhibitorsIBA
11/2004
1trichostatin A (A 300)IBA
11/2004
14-phenylbutyric acid (Buphenyl)FDA Link
11/2004
1Ro 41-5253IBA
11/2004
1theasinensin AIBA
11/2004
1Hormones (Hormone)IBA
11/2004
1RetinoidsIBA
11/2004
1Tretinoin (Retinoic Acid)FDA LinkGeneric
11/2004

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2004